Worth noting that the EMA says (in bold): > the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and dea

Worth noting that the EMA says (in bold): > the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects. https://www.ema.europa.eu/en/news/emas-safety-committee-continues-investigation-covid-19-vaccine-astrazeneca-thromboembolic-events https://www.ema.europa.eu/en/news/emas-safety-committee-cont...